Schuler's Biodesix Stake Hits 22.3% After $1.0M Post-Guidance-Cut Buy
BDSX sits 92% above its 52-week low of $5.26 on elevated volume (3.6× avg).
Summary
Biodesix 10% owner and Emeritus Director Jack Schuler raised his beneficial stake to 22.3%, or 2,476,545 shares, after buying 100,000 shares for about $1.0 million at a weighted average of $10.0199 on November 10, two days after the Q3 revenue miss and guidance cut.
Key Events · Ownership and Investor Activity · BDSX
-
Schuler Buys $1.0M After Guidance Cut
On 2026-11-10, Jack W. Schuler bought 100,000 shares through the Jack W. Schuler Living Trust at a weighted average of $10.0199, about $1.0 million, in transactions ranging from $9.655 to $10.25.
-
Beneficial Stake Reaches 22.3%
Mr. Schuler beneficially owns 2,476,545 shares, approximately 22.3% of the 11,088,511 shares outstanding as of October 30, 2026, including 20,735 shares acquirable within 60 days.
-
Trust Structure Holds the Position
The Living Trust holds 655,810 shares (5.9%) and the 2026 GRAT holds 1,800,000 shares (16.2%); 750,000 shares moved from the 2025 GRAT to the Trust on 2026-03-25 and 1,800,000 moved to the 2026 GRAT on 2026-04-01, both for no consideration.
-
August Buys Disclosed at ~$24
The amendment first discloses 13,900 shares bought on 2026-08-10 at a weighted average of $24.2467, 13,700 on 2026-08-11 at $24.0081 and 15,000 on 2026-08-12 at $24.4661, well above today's $10.12 price.
Analysis · BDSX · Industrial Applications And Services
Jack Schuler, a 10% owner and Emeritus Director, now beneficially owns 2,476,545 shares, or 22.3% of Biodesix, after buying 100,000 shares for about $1.0 million at a weighted average of $10.0199 on November 10. That purchase came two days after Q3 revenue of $24.0 million missed the $27.5 million estimate by roughly 13% and full-year 2026 guidance was cut, so a holder of this size adding at the post-selloff price is the most concrete vote of confidence management has received this quarter. The amendment also reveals August buys at roughly $24 per share, meaning his recent accumulation spans a much higher price level than today's $10.12, and it lays out the trust structure holding the position. The concentration itself is the risk: with 22.3% in one holder's hands, his future buying or selling decisions carry outsized weight on the stock.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BDSX was trading at $10.12 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $112.2M. The 52-week trading range was $5.26 to $31.97. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.